Nature Discusses Therapeutic Genome Editing, Presents Fitness Consequence Map of Rice, More

Feb 13, 2020

University of California, Berkeley, researcher and CRISPR pioneer Jennifer Doudna reviews the scientific, technical, and ethical aspects of using the genome editing technology for therapeutic applications in this week's Nature. In her review, she presents examples highlighting both the potential and pitfalls of these efforts, and calls for "active efforts to ensure that this breakthrough technology is used responsibly to treat, cure, and prevent genetic disease."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Featured White Papers

Genomic Solutions for Sensitive Viral Detection

Increased DNA Yield and Reduced PCR Duplicates Using the Ionic System

Isotachophoresis Improves Nucleic Acid Extraction and Purification from FFPE Samples

AI in Genomics: Progress through Innovation

Sep

30

Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.

Oct

06

Featured Webinar

Understanding Human Pulmonary Fibrosis using Single-Cell Technologies

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure.

Oct

08

Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct

13

Featured Webinar

Probing and Disrupting Oncogenic Gene Control via Targeted Protein Degradation

This webinar will outline the use of targeted protein degradation (TPD) to understand transcriptional processes at a high kinetic resolution.

Menu